The CERS3 Gene Ichthyosis Congenital Autosomal Recessive Type 9 Genetic Test is a specialized diagnostic examination available at DNA Labs UAE, designed to identify mutations in the CERS3 gene, which are linked to a rare form of ichthyosis. This condition, known as Autosomal Recessive Congenital Ichthyosis Type 9 (ARCI9), is characterized by severe skin abnormalities that are present from birth, including scaling, dryness, and in some cases, complications with temperature regulation and barrier functions of the skin.
The test is aimed at individuals who have clinical symptoms of the condition or have a family history of ichthyosis, providing crucial information for accurate diagnosis, management, and genetic counseling. By analyzing the patient's DNA, the test can confirm the presence of mutations in the CERS3 gene that are responsible for the condition, facilitating personalized treatment plans and informing family planning decisions.
The cost of the CERS3 Gene Ichthyosis Congenital Autosomal Recessive Type 9 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis necessary to detect the specific genetic alterations associated with this form of ichthyosis, leveraging advanced genomic technologies to ensure high accuracy and reliability of results.
The ABCA12 Gene Ichthyosis Lamellar Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the ABCA12 gene, which are responsible for Ichthyosis Lamellar Type 2, a rare genetic skin disorder. This condition is characterized by the presence of dark, plate-like scales over the body, caused by a defect in skin barrier formation due to the mutation. The test is crucial for early diagnosis, enabling timely intervention and management of the condition to improve the quality of life of affected individuals. The cost of the test is 4400 AED, making it a valuable investment for families with a history of this condition, aiming to provide them with accurate diagnosis and genetic counseling.
The "CYP4F22 Gene Ichthyosis Lamellar Type 3 Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CYP4F22 gene, which are linked to the development of Lamellar Ichthyosis Type 3. Lamellar Ichthyosis is a rare genetic skin disorder characterized by the formation of large, dark, plate-like scales covering the body. This condition is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The test aims to provide crucial genetic information that can assist in the early diagnosis and management of the condition. By identifying specific mutations in the CYP4F22 gene, healthcare providers can offer personalized treatment plans, genetic counseling, and support for affected individuals and their families. The genetic test is performed using a sample of the patient's DNA, typically extracted from a blood sample.
At DNA Labs UAE, the cost of the CYP4F22 Gene Ichthyosis Lamellar Type 3 Genetic Test is set at 3200 AED. This investment in genetic testing can be invaluable for families seeking answers to their loved one's condition, enabling them to make informed health and lifestyle decisions.
The LIPN Gene Ichthyosis Lamellar Type 4 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the LIPN gene, which are associated with Ichthyosis Lamellar Type 4. This condition is a rare genetic skin disorder characterized by the formation of large, dark scales on the skin's surface, often leading to significant discomfort and potential complications. The test is crucial for accurate diagnosis, enabling targeted treatment and management strategies for affected individuals. Priced at 4400 AED, this genetic test involves analyzing the patient's DNA to detect any abnormalities in the LIPN gene, providing essential information for healthcare providers, patients, and their families. By offering this test, DNA Labs UAE plays a vital role in the early detection and intervention of Ichthyosis Lamellar Type 4, improving patient outcomes and quality of life.
The CLDN1 Gene Ichthyosis Leukocyte Vacuoles Alopecia and Sclerosing Cholangitis Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the CLDN1 gene. This gene plays a critical role in maintaining the integrity of cell barriers and its mutations are associated with a rare but complex syndrome characterized by ichthyosis (a condition causing dry, scaly skin), leukocyte vacuoles (abnormalities in white blood cells), alopecia (hair loss), and sclerosing cholangitis (a disease affecting the bile ducts). The test, priced at 4400 AED, is crucial for accurate diagnosis, enabling personalized treatment plans and providing essential information for family planning. DNA Labs UAE employs cutting-edge genetic testing technologies to ensure reliable and precise results, supporting patients and healthcare professionals in managing this multifaceted condition.
The ELOVL4 Gene Ichthyosis Spastic Quadriplegia and Mental Retardation Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE. This test is designed to identify mutations in the ELOVL4 gene, which are known to cause a rare and complex condition characterized by congenital ichthyosis (a disorder causing dry, thickened, scaly skin), spastic quadriplegia (a form of cerebral palsy affecting all four limbs), and mental retardation.
The test, priced at 4400 AED, is conducted through a comprehensive analysis of the patient's DNA, extracted from a blood sample. By pinpointing specific genetic mutations in the ELOVL4 gene, healthcare professionals can confirm the diagnosis of this condition, enabling them to provide targeted care and support for affected individuals and their families.
DNA Labs UAE utilizes advanced genetic sequencing technologies to ensure accurate and reliable results, making it an invaluable resource for families seeking answers to complex genetic conditions. The test not only aids in the diagnosis but also helps in understanding the prognosis of the condition and in some cases, can guide therapeutic interventions and management strategies tailored to the patient's genetic profile.
The STS Gene Ichthyosis X-linked genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the STS gene, which are responsible for X-linked ichthyosis (XLI). XLI is a skin disorder characterized by the formation of large, dark, and adherent scales, primarily affecting males due to its X-linked recessive inheritance pattern. This condition is caused by a deficiency in the enzyme steroid sulfatase, which is crucial for cholesterol sulfate metabolism in the skin. The deficiency leads to the accumulation of cholesterol sulfate, resulting in the skin abnormalities seen in XLI.
The test is particularly important for individuals showing symptoms of XLI, families with a history of the condition, or couples considering pregnancy and wanting to assess their risk of having a child with XLI. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the STS gene.
At DNA Labs UAE, the STS Gene Ichthyosis X-linked genetic test is offered at a cost of 4400 AED. The price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify mutations in the STS gene. Results from this test can provide crucial information for diagnosis, allowing affected individuals and their families to understand their condition better and explore potential treatment and management options.
The "ICOS Gene Immunodeficiency Common Variable Type 1 Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the ICOS gene, which are linked to Common Variable Immunodeficiency Type 1 (CVID1). This condition is characterized by a significant reduction in the levels of serum immunoglobulins (antibodies), leading to an increased susceptibility to infections, autoimmune disorders, and potentially, an increased risk of cancer. The test is crucial for individuals exhibiting symptoms suggestive of immunodeficiency disorders or for those with a family history of CVID1, as it aids in the precise diagnosis and subsequent management of the condition. The cost of the test is set at 4400 AED, reflecting the intricate technologies and expertise involved in genetic analysis and interpretation. Conducted at the state-of-the-art facilities of DNA Labs UAE, this genetic test stands as a pivotal tool in the realm of personalized medicine, offering insights that can guide therapeutic decisions and improve patient outcomes.
The "NFKB2 Gene Immunodeficiency Common Variable Type 10 Genetic Test" is a specialized diagnostic tool designed to identify mutations in the NFKB2 gene, which are associated with Common Variable Immunodeficiency Type 10 (CVID10). This condition is a form of primary immunodeficiency characterized by a decrease in the levels of serum immunoglobulins (antibodies) leading to an increased susceptibility to infections. Symptoms can include recurrent bacterial infections, autoimmune disorders, and an increased risk of certain types of cancer.
The test is crucial for individuals exhibiting symptoms suggestive of CVID10 or those with a family history of immunodeficiency disorders, as early diagnosis can significantly improve management and prognosis. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test employs advanced genomic technologies to accurately detect alterations in the NFKB2 gene.
The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and detailed insights it provides. The results from this test can guide healthcare professionals in developing a personalized treatment plan for affected individuals, which may include immunoglobulin replacement therapy, antibiotics for infection prevention, and other supportive treatments.
Given its specialized nature, the NFKB2 Gene Immunodeficiency Common Variable Type 10 Genetic Test is a valuable resource for both patients and clinicians in the effective management of this complex immunodeficiency disorder.
The TNFRSF13B gene, also known as TACI, plays a crucial role in the immune system, particularly in the regulation and function of B cells, which are essential for producing antibodies. Mutations in the TNFRSF13B gene can lead to immunodeficiency common variable type 2 (CVID2), a condition characterized by a significant reduction in the levels of immunoglobulins. This reduction makes individuals more susceptible to infections, autoimmune diseases, and potentially an increased risk of certain cancers.
The genetic test for identifying mutations in the TNFRSF13B gene is a critical tool for diagnosing CVID2. Conducted at DNA Labs UAE, this test involves analyzing the patient's DNA to detect any genetic alterations associated with the condition. The process provides vital information that can help in understanding the patient's symptoms, predicting the disease course, and tailoring the management plan to improve the quality of life.
The cost of the TNFRSF13B Gene Immunodeficiency Common Variable Type 2 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the expenses related to the sophisticated laboratory techniques and expertise required to accurately identify mutations in the TNFRSF13B gene. Given the complexity of CVID2 and the significance of genetic factors in its management, this test represents a valuable resource for patients and healthcare providers alike, offering insights that can lead to more effective and personalized care.
